Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL
2013; Springer Nature; Volume: 28; Issue: 4 Linguagem: Inglês
10.1038/leu.2013.245
ISSN1476-5551
AutoresJ A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam,
Tópico(s)Chronic Myeloid Leukemia Treatments
Referência(s)